Comments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis"
- PMID: 26261680
- PMCID: PMC4526014
Comments on Bu et al. "P16(INK₄a) overexpression and survival in osteosarcoma patients: a meta analysis"
Abstract
Recently, we read the article "P16(INK4a) overexpression and survival in osteosarcoma patients: a meta analysis" by Jie Bu and his colleagues, published in the recent issue of International Journal Of Experimental Pathology. This research performed a meta-analysis to uncover the role of P16(INK4a) expression in overall survival rate in patients with osteosarcoma. The investigators concluded as follows: (i) the pateints with overexpression of P16(INK4a) had a longer overall survival rate than that with loss expression of P16(INK4a); (ii) P16(INK4a) was an effective biomarker of prognosis in patients with osteosarcoma.The findings are valubale and encouraging. However, some flaws and imperfections rooted in this work.
Keywords: Osteosarcoma; P16INK4a; meta-analysis.
Comment on
-
P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.Int J Clin Exp Pathol. 2014 Aug 15;7(9):6091-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337256 Free PMC article. Review.
Similar articles
-
Comments on the article of Bu, et al entitled "P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis".Int J Clin Exp Pathol. 2015 Mar 1;8(3):3384-5. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26045875 Free PMC article. No abstract available.
-
P16INK4a overexpression and survival in osteosarcoma patients: a meta analysis.Int J Clin Exp Pathol. 2014 Aug 15;7(9):6091-6. eCollection 2014. Int J Clin Exp Pathol. 2014. PMID: 25337256 Free PMC article. Review.
-
p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.Hum Pathol. 2016 Dec;58:15-23. doi: 10.1016/j.humpath.2016.07.023. Epub 2016 Aug 18. Hum Pathol. 2016. PMID: 27544803
-
p16 expression predicts neoadjuvant tumor necrosis in osteosarcomas: reappraisal with a larger series using whole sections.Hum Pathol. 2016 Apr;50:170-5. doi: 10.1016/j.humpath.2015.09.043. Epub 2015 Dec 18. Hum Pathol. 2016. PMID: 26997452
-
P16 protein expression as a useful predictive biomarker for neoadjuvant chemotherapy response in patients with high-grade osteosarcoma: A systematic meta-analysis under guideline of PRISMA.Medicine (Baltimore). 2017 May;96(19):e6714. doi: 10.1097/MD.0000000000006714. Medicine (Baltimore). 2017. PMID: 28489748 Free PMC article. Review.
References
-
- Xiao Z, Cai Y, Lin Q. Preliminary research on the expression of rumor suppressor gene p16 protein in human osteosarcoma. Zhejiang Clin Med J. 2000:653–654.
-
- Li L, Wang Y, Liu Y, Li Z. Clinical signification of express of tumor supressor genes and proliferative in osteosarcoma. J Clin Orthop. 1999:164–166.
-
- Meng L, Yu X, Du D, Wang G. The expression and significance of the P16 gene in osteosarcoma. Shandong Med J. 1999:19–20.
-
- Lei N, Pan X, Qi Y, Fang Y. Expressions of P16 and proliferating cell nuclear antigen in osteosarcoma and clinical significances. J Jilin Univ-Med. 2009:519–521.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical